
Iambic Therapeutics, Inc. is a clinical‑stage biotech that harnesses an AI‑driven platform to accelerate the discovery of novel medicines. Founded in 2020 and headquartered in San Diego, the company blends cutting‑edge AI expertise with seasoned drug hunters to generate first‑in‑class and best‑in‑class therapeutic candidates. Its platform has consistently moved new drug candidates into human trials at industry‑leading speed across diverse target classes and mechanisms of action. By focusing on urgent unmet medical needs, Iambic delivers a pipeline of high‑potential assets that differentiate it as a fast‑moving, data‑centric innovator in the biopharma landscape.
Iambic Therapeutics is seeking an exceptional scientific leader to serve as Head of Translational Oncology. This role is responsible for leading classical translational science, operationalizing bidirectional learning between translational/clinical data and AI/ML models, and defining biomarker & patient selection strategy.
Iambic Therapeutics, Inc. is a clinical‑stage biotech that harnesses an AI‑driven platform to accelerate the discovery of novel medicines. Founded in 2020 and headquartered in San Diego, the company blends cutting‑edge AI expertise with seasoned drug hunters to generate first‑in‑class and best‑in‑class therapeutic candidates. Its platform has consistently moved new drug candidates into human trials at industry‑leading speed across diverse target classes and mechanisms of action. By focusing on urgent unmet medical needs, Iambic delivers a pipeline of high‑potential assets that differentiate it as a fast‑moving, data‑centric innovator in the biopharma landscape.